Skip to main content
. 2016 Feb 9;7(11):12568–12581. doi: 10.18632/oncotarget.7276

Figure 9. Inhibition of ERRα by XCT-790 inhibits the MDA-MB-231 xenograft growth in vivo.

Figure 9

(A) Tumor size was measured at the indicated time intervals. (B) The proteins related to the growth inhibition effects of XCT-790 were determined by Western blot analysis in the tumor lysates from the control and XCT-790 treated group. *p < 0.05 compared with control; **p < 0.01 compared with control.